PT  - JOURNAL ARTICLE
AU  - Meher K. Prakash
TI  - Bringing accountability to the peak of the pandemic using linear response theory
AID  - 10.1101/2020.04.21.20068478
DP  - 2020 Jan 01
TA  - medRxiv
PG  - 2020.04.21.20068478
4099  - http://medrxiv.org/content/early/2020/04/27/2020.04.21.20068478.short
4100  - http://medrxiv.org/content/early/2020/04/27/2020.04.21.20068478.full
AB  - The peak of the daily new infections in COVID-19 remained qualitative in description and elusive in arrival. Because of the lack of clarity in what to expect from the peak, apart from the hope that one day the peak will be reached, there has been no metric to describe the success of the implemented strategies. We propose a way of predicting the number of infections that can be expected after a lockdown, assuming they come from the asymptomatic cases prior to the lockdown and using linear response theory. These predictions for several western countries faithfully follow the observed infections for several weeks after the lockdown, suggesting universalities in the recovery pattern of several countries. At the same time, the gap between the quantitative predictions of the recovery patterns for New York and Milan and the observations is striking. These gaps which arise even while emulating the recovery patterns of other western countries raise the possibility of an audit of the success of the implemented strategies, and the potential newer sources of infection.Competing Interest StatementThe authors have declared no competing interest.Funding StatementNo funding has been receivedAuthor DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe analyses have been performed from publicly available data. However, upon request the specific analysis folders including the data and scripts will be provided.